Fig. 9From: Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cellsDiagram of molecular mechanism. Alantolactone inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells via impairment of mitochondrial homeostasis and downregulation of Drp1 phosphorylationBack to article page